Screening, Surveillance, and Management of Hepatocellular Carcinoma During the COVID-19 Pandemic: a Narrative Review

dc.authoridYilmaz, Sezai/0000-0002-8044-0297
dc.authoridGARZALI, IBRAHIM UMAR/0000-0002-9797-851X
dc.authoridAkbulut, Sami/0000-0002-6864-7711
dc.authoridaloun, ali/0000-0002-3548-6536
dc.authorwosidYilmaz, Sezai/ABI-2323-2020
dc.authorwosidGARZALI, IBRAHIM UMAR/ITU-1475-2023
dc.authorwosidHargura, Abdirahman Sakulen/GQQ-8646-2022
dc.authorwosidAkbulut, Sami/L-9568-2014
dc.contributor.authorAkbulut, Sami
dc.contributor.authorGarzali, Ibrahim Umar
dc.contributor.authorHargura, Abdirahman Sakulen
dc.contributor.authorAloun, Ali
dc.contributor.authorYilmaz, Sezai
dc.date.accessioned2024-08-04T20:51:55Z
dc.date.available2024-08-04T20:51:55Z
dc.date.issued2023
dc.departmentİnönü Üniversitesien_US
dc.description.abstractPurpose The COVID-19 pandemic has been a burden to the global community as a whole but the healthcare community had bore the brunt of it. The pandemic resulted in policy changes that interfered with effective healthcare delivery. The healthcare community attempted to cope with the pandemic by triaging and prioritizing emergency conditions especially COVID related, ahead of elective conditions like cancer care. There was also fear that patients with cancer were at an increased risk of sever COVID-19 with increased mortality. Hepatocellular carcinoma (HCC) was also affected by these policies. Methods We reviewed the modified measures adopted in screening, surveillance, and management of HCC during the pandemic using PubMed, Medline, Index Medicus, EMBASE, SCOPUS, and Google Scholar databases. Result The main modification in surveillance and screening for HCC during the pandemic includes limiting the surveillance to those with very high risk of HCC. The interval between surveillan was also delayed by few months in some cases. The adoption of teleconferencing for multidisciplinary team meetings and patient consultation is one of the highlights of this pandemic all in an effort to reduce contact and spread of the virus. The treatment of early-stage HCC was also modified as needed. The role of ablative therapy in the management of early HCC was very prominent during the pandemic as the surgical therapy was significantly affected by the lacks of ventilators and intensive care unit space resulting from the pandemic. Transplantation, especially living donor liver transplantation, was suspended in few centers because of the risk of infection to the living donors. Conclusion As we gradually recover from the pandemic, we should prepare for the fallout from the pandemic as we may encounter increased presentation of those patients deferred from screening during the pandemic.en_US
dc.identifier.doi10.1007/s12029-022-00830-2
dc.identifier.endpage419en_US
dc.identifier.issn1941-6628
dc.identifier.issn1941-6636
dc.identifier.issue2en_US
dc.identifier.pmid35499649en_US
dc.identifier.scopus2-s2.0-85129336040en_US
dc.identifier.scopusqualityQ3en_US
dc.identifier.startpage408en_US
dc.identifier.urihttps://doi.org/10.1007/s12029-022-00830-2
dc.identifier.urihttps://hdl.handle.net/11616/100630
dc.identifier.volume54en_US
dc.identifier.wosWOS:000789758700002en_US
dc.identifier.wosqualityN/Aen_US
dc.indekslendigikaynakWeb of Scienceen_US
dc.indekslendigikaynakScopusen_US
dc.indekslendigikaynakPubMeden_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofJournal of Gastrointestinal Canceren_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectHepatocellular carcinomaen_US
dc.subjectLiver resectionen_US
dc.subjectLiver transplantationen_US
dc.subjectScreeningen_US
dc.subjectSurveillanceen_US
dc.subjectCOVID-19 pandemicen_US
dc.titleScreening, Surveillance, and Management of Hepatocellular Carcinoma During the COVID-19 Pandemic: a Narrative Reviewen_US
dc.typeReview Articleen_US

Dosyalar